Found: 1
Select item for more details and to access through your institution.
Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 12, p. 1841, doi. 10.1007/s00262-013-1493-8
- By:
- Publication type:
- Article